Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $21.58, for a total value of $215,800.00. The sale was disclosed in a document filed with the SEC, which can be […]
Wedbush reaffirmed their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $41.00 price target on the stock. Wedbush also issued estimates for Aerovate Therapeutics’ Q2 2024 earnings at ($0.71) EPS, Q3 2024 earnings at ($0.66) EPS, Q4 2024 earnings […]
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 11,357 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $20.34, for a total transaction of $231,001.38. The sale was disclosed in a filing with the Securities & Exchange Commission, […]
Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw an uptick in trading volume on Wednesday . 197,194 shares changed hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Analyst Ratings Changes Several analysts have recently […]